Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (246)
- Medicines safety (146)
- COVID-19 (144)
- Prescription medicines (129)
- Regulatory compliance (120)
- COVID-19 vaccines (88)
- Legislation (78)
- Therapeutic goods regulation (71)
- Listed medicines (48)
- Non-prescription medicines (43)
- Medical devices safety (42)
- Safety (40)
- Vaping hub (33)
- Complementary medicines (30)
- Manufacturing (28)
- Labelling and packaging (25)
- Assessed listed medicines (24)
- Scheduling (national classification system) (23)
- Over the counter (OTC) medicines (21)
- Compliance and enforcement hub (20)
- Medicinal cannabis hub (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (17)
- Alert/Advisory (12)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Registered complementary medicines (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1055 result(s) found, displaying 826 to 850
-
NoticesA new S41BD(3) instrument has been signed to declare that some nappy rash products are not to be medical devices for the purposes of the Act
-
NoticesThe Permissible Ingredients Determination has been updated.
-
-
NoticesThis instrument is made under regulation 5F of the Therapeutic Goods Regulations 1990.
-
Media releasesWe will closely consider the judgment including any further improvements that could enhance the regulatory system in Australia.
-
NoticesThe Permissible Ingredients Determination has been updated.
-
Media releasesAcalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada
-
Media releasesConsumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
-
Media releasesThe TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance
-
BlogFrom animals intestines to intrauterine devices, contraception has a fascinating history.
-
NewsGeneral information for consumers on prescription opioids
-
Media releasesThe Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications
-
NoticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
-
BlogBe informed and aware, but don’t be afraid.
-
Media releasesThe Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
Media releasesChanges are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements
-
BlogLearn about the evidence for medicinal cannabis, and how a medical doctor can organise medicinal cannabis access on behalf of appropriate patients.
-
BlogWhat does Neo from the Matrix need to know before choosing a pill to take?
-
NoticesJapan has recently been added to the list of Foreign Countries and Jurisdictions determined to be comparable overseas regulators
-
NoticesTherapeutic Goods (Declared Goods) Order 2019 consolidates and replaces several instruments
-
NewsConsidering microneedling? Make sure you do your research first
-
BlogContamination has been discovered in some ranitidine products, but the immediate health risk is low.
-
BlogConsumer Medicine Information gives you the information you need to manage your health